Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 29Unknown 8Active not recruiting 3Withdrawn 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Large B-Cell, Diffuse 14Lymphoma 12Burkitt Lymphoma 12Neoplasms 8Lymphoma, Follicular 8Lymphoma, B-Cell 6Rhabdomyosarcoma 5Medulloblastoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Hodgkin Disease 4Retinoblastoma 3Recurrence 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell, Marginal Zone 3Central Nervous System Neoplasms 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Rhabdoid Tumor 2Neuroectodermal Tumors, Primitive 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, AIDS-Related 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Leukemia 2

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 4Cisplatin 4Biopsy 4selpercatinib 3larotrectinib 3Vincristine 3Carboplatin 3erdafitinib 2ensartinib 2Temozolomide 2Radiotherapy 2Methotrexate 2Cyclophosphamide 2Chemotherapy, Adjuvant 2ulixertinib 1tipifarnib 1tazemetostat 1palbociclib 1olaparib 1niraparib 1neratinib 1lenvatinib 1ivosidenib 1ibrutinib 1entrectinib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Central Nervous System Neoplasms × Vincristine × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

NCT00887146 2026-01-22

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
305 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡